Mark Dawson is Vice President of Manufacturing and Supply Chain for Primary and Established Products (PEP) within GSK’s Pharmaceutical business.
Based out of GSK Asia headquarters in Singapore, Mark leads the supply chain that manufactures all GSK Primary (API) products, Antibiotics supply chain and Regional Rx manufacturing with 18 facilities located across Europe, Latin America, MEA, India, China, Singapore and Australia. Additionally, he is also accountable for all supply chain planning, logistics and warehousing operations into 105 global markets from Latin America, Middle East, Africa, Russia/CIS, India, Pakistan, China and South Asia.
Mark is a member of the Pharma Supply Chain Executive Team and the Emerging Markets Leadership Team. He also sits as a member of GSK’s Global Gender Diversity Council.
Mark joined GSK in 2005 working in various roles of increasing seniority within Global Manufacturing and Supply as Engineering Director, Site Director for the Irvine manufacturing site, VP and Head of Global Supply Chain within ViiV Healthcare (GSK’s HIV business) and latterly as VP and Head of Supply Chain for Emerging Markets.
Prior to GSK, Mark worked for several multinational companies including Eli Lilly & Company, Kvaerner and Schneider Electric. Mark is a graduate of the University of Sheffield in the UK and a Chartered Engineer.